HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 370.50
Day range
kr 372.00 - kr 380.00
Year range
kr 205.50 - kr 385.50
Market cap
11.91B SEK
Avg Volume
67.10K
P/E ratio
113.96
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 186.02M | 32.29% |
Operating expense | 116.11M | 24.04% |
Net income | 22.78M | 60.73% |
Net profit margin | 12.25 | 21.53% |
Earnings per share | 0.75 | 46.04% |
EBITDA | 28.54M | 73.57% |
Effective tax rate | 24.07% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 511.15M | 158.22% |
Total assets | 2.25B | 29.53% |
Total liabilities | 250.54M | -14.49% |
Total equity | 2.00B | — |
Shares outstanding | 31.50M | — |
Price to book | 5.83 | — |
Return on assets | 2.13% | — |
Return on capital | 2.37% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 22.78M | 60.73% |
Cash from operations | 1.59M | 112.80% |
Cash from investing | -42.50M | -26.75% |
Cash from financing | -2.37M | 4.75% |
Net change in cash | -34.94M | 28.10% |
Free cash flow | 11.66M | 128.38% |
About
Founded
1998
Website
Employees
148